PREMPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prempro, and what generic alternatives are available?
Prempro is a drug marketed by Wyeth Pharms and Wyeth Pharms Inc and is included in two NDAs.
The generic ingredient in PREMPRO is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.
Summary for PREMPRO
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 14 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PREMPRO |
| What excipients (inactive ingredients) are in PREMPRO? | PREMPRO excipients list |
| DailyMed Link: | PREMPRO at DailyMed |
Recent Clinical Trials for PREMPRO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pfizer | Phase 3 |
| MDS Pharma Services | Phase 1 |
| Bayer | Phase 2 |
Pharmacology for PREMPRO
| Drug Class | Estrogen Progestin |
| Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PREMPRO
US Patents and Regulatory Information for PREMPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-005 | Jun 4, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-003 | Jan 9, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-004 | Mar 12, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-001 | Nov 17, 1995 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PREMPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-001 | Nov 17, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-001 | Nov 17, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-005 | Jun 4, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-004 | Mar 12, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-005 | Jun 4, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PREMPRO
See the table below for patents covering PREMPRO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Philippines | 24052 | A METHOD OF HORMONAL TREATMENT OF PERIMENOPAUSAL,MENOPAUSAL AND POST-MENOPAUSAL DISORDERS | ⤷ Try a Trial |
| Denmark | 200400365 | ⤷ Try a Trial | |
| Singapore | 33663 | Novel sugar coating composition for application to compressed medicinal tablets | ⤷ Try a Trial |
| Argentina | 002019 | UNA COMPOSICION DE RECUBRIMIENTO DE AZUCAR PARA APLICACION A UNA TABLETA MEDICINAL COMPRIMIDA, Y UNA TABLETA COMPRIMIDA. | ⤷ Try a Trial |
| Colombia | 4370096 | LIBERACION CONTROLADA DE ESTEROIDES A PARTIR DE REVESTIMIENTOS DE AZUCAR | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREMPRO
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0136011 | SPC/GB98/034 | United Kingdom | ⤷ Try a Trial | SPC/GB98/034: 20040802, EXPIRES: 20090801 |
| 0136011 | SPC/GB97/032 | United Kingdom | ⤷ Try a Trial | SPC/GB97/032: 20040802, EXPIRES: 20090801 |
| 0136011 | 97C0056 | Belgium | ⤷ Try a Trial | PRODUCT NAME: OESTROGENES CONJUGUES + MEDROXYPROGESTERONACETAS; NAT. REGISTRATION NO/DATE: 428 IS 194 F 3 19970520; FIRST REGISTRATION: CH 52649 19940826 |
| 0136011 | SPC/GB00/028 | United Kingdom | ⤷ Try a Trial | SPC/GB00/028: 20040802, EXPIRES: 20090801 |
| 0136011 | 91096 | Luxembourg | ⤷ Try a Trial | 91096, EXPIRES: 20090802 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
